Abstract
The series of new acetylenic thioquinolines containing propargyl, 2-butynyl, 4-bromo-2-butynyl, and 4-hydroxy-2-butynyl groups has been prepared and tested for antiproliferative activity in vitro against human [SW707 (colorectal adenocarcinoma), CCRF/CEM (leukemia)] and murine [P388 (leukemia), B16 (melanoma)] cancer lines. All the compounds obtained exhibited antiproliferative activity. The most active compounds 7, 16, 17, and 19 have the ID(50) values ranging from 0.2 to 4.6 microg/ml comparable to that of cisplatin used as reference compounds.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Colorectal Neoplasms / drug therapy*
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
Humans
-
Leukemia, Experimental / drug therapy*
-
Melanoma, Experimental / drug therapy*
-
Mice
-
Molecular Structure
-
Quinolines / chemical synthesis
-
Quinolines / chemistry
-
Quinolines / pharmacology*
-
Stereoisomerism
-
Structure-Activity Relationship
-
Sulfides / chemical synthesis
-
Sulfides / chemistry
-
Sulfides / pharmacology*
Substances
-
Antineoplastic Agents
-
Quinolines
-
Sulfides